Vimarsana
Biggest News Aggregation in the World

Page 7 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

Tekla Capital Management LLC Invests $316,000 in Altimmune, Inc. (NASDAQ:ALT) - Vimarsana News

Tekla Capital Management LLC Invests $316,000 in Altimmune, Inc. (NASDAQ:ALT)

Tekla Capital Management LLC acquired a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 75,000 shares of the company’s stock, valued at approximately $316,000. Tekla Capital Management LLC owned approximately […]

Critical Contrast: Altimmune (NASDAQ:ALT) & Purple Biotech (NASDAQ:PPBT) - Vimarsana News

Critical Contrast: Altimmune (NASDAQ:ALT) & Purple Biotech (NASDAQ:PPBT)

Altimmune (NASDAQ:ALT – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares Altimmune and Purple Biotech’s […]

Financial Contrast: Altimmune (NASDAQ:ALT) and Incannex Healthcare (NASDAQ:IXHL) - Vimarsana News

Financial Contrast: Altimmune (NASDAQ:ALT) and Incannex Healthcare (NASDAQ:IXHL)

Altimmune (NASDAQ:ALT – Get Free Report) and Incannex Healthcare (NASDAQ:IXHL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Profitability This table compares Altimmune and Incannex Healthcare’s […]

Source: wkrb13.com
With 68% institutional ownership, Altimmune, Inc. (NASDAQ:ALT) is a favorite amongst the big guns - Vimarsana News

With 68% institutional ownership, Altimmune, Inc. (NASDAQ:ALT) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, Altimmune's stock price might be vulnerable to their...

Source: yahoo.com
Altimmune, Inc. (NASDAQ:ALT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Altimmune, Inc. (NASDAQ:ALT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Altimmune, Inc. (NASDAQ:ALT – Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price […]